IR Information
About Our Company
Our Vision
Management
Corporate Information
Our History
About Our Business
Business Model
R&D Pipelines
News
Policy
Privacy Policy
Anonymously Processing Informations
IR News
IR News
Management Information
IR Library
Other IR Information
FAQ
Japanese
TOP
>
IR News
IR News
2025.02.18
Timely Disclosure
Announcement of initiation (patient administration begins) of the Phase III trial of malignant melanoma treatment drug RS5614
(166KB)
2025.02.12
Timely Disclosure
Notice of receipt of lump sum payment due to the exercise of option right by Chest Co., Ltd. for the artificial intelligence (AI)-based medical software to diagnose respiratory diseases by the spirometry
(112KB)
2025.01.27
Timely Disclosure
Frequently Asked Questions and Answers
(137KB)
2025.01.22
Timely Disclosure
Opening of the laboratory of the Potocsnak Longevity Institute of Northwestern University at the Tohoku University Renascience Open Innovation Lab (TREx)
(265KB)
2025.01.16
Timely Disclosure
Prompt announcement of the result of the clinical performance test for the artificial intelligence
(113KB)
IR News List
Management Information
To Our Shareholders and Investors
Corporate Governance
IR Library
IR Library List
Financial Results
Presentation Materials
General Meeting of Shareholders Materials
Timely Disclosure Information
Other IR Information
Stock Information
IR Calendar
Disclosure Policy
Disclaimer
IR Contact
For IR inquiries, please contact us here.